A carregar...

Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance

Mitochondria are currently known as novel targets for treating cancer, especially for tumors displaying multidrug resistance (MDR). This present study aimed to develop a mitochondria-targeted delivery system by using triphenylphosphonium cation (TPP(+))-conjugated Brij 98 as the functional stabilize...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asian J Pharm Sci
Main Authors: Han, Xue, Su, Ruijuan, Huang, Xiuqing, Wang, Yingli, Kuang, Xiao, Zhou, Shuang, Liu, Hongzhuo
Formato: Artigo
Idioma:Inglês
Publicado em: Shenyang Pharmaceutical University 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7032231/
https://ncbi.nlm.nih.gov/pubmed/32104484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajps.2018.06.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!